Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohortAndrea Serafin, Andrea Visentin, Riccardo Moia et al.|Blood Advances|2025Cited by 3
Real‐life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy‐cell leukemia: A multicenter Italian retrospective study (HCL‐PG03R)Enrico Tiacci, Monia Capponi, Andrea Bernardelli et al.|HemaSphere|2025Cited by 1
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control studyAlberto Fresa, Luca Laurenti, Idanna Innocenti et al.|Blood Advances|2025Cited by 0
Real-world treatment patterns and outcomes in patients with CLL and cardiovascular comorbidities: Interim analysis of the multicenter study conducted by eric.Thomas Chatzikonstantinou, Lydia Scarfò, Persefoni Talimtzi et al.|Blood|2025Cited by 0